TH-302 (evofosfamide)

evofosfamide · Threshold Pharmaceuticals

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TH-302 (evofosfamide), covering 2016-06-10 to 2017-12-15. Get the full timeline:

Most recent: Clinical Trial Update: Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic Cancer [Phase 1]